Clinical Trial Update: Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of cabozantinib with abiraterone in chemotherapy-naïve, bone-metastatic castration-resistant prostate cancer has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Zykadia (ceritinib)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: Exelixis | Conditions: Prostate Cancer, Castration Resistant Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2026-01-08